PuREC secures $5.8 mil series B financing with Mochida Pharma, San-in Godo Bank and other parties.
PuREC, a clinical-stage biotech startup with unique MSC cell therapy “REC”, has raised JPY 7.0 billion ($5.8 million) with third-party...
PuREC secures $5.8 mil series B financing with Mochida Pharma, San-in Godo Bank and other parties.
PuREC receives JETRO Kyoto Award at "3rd Kyoto Univesity Life Science Showcase @ San Diego 2022"
Genesis 2021 Innovation Workshop at LINK-J session
Japan Healthcare Venture Summit (JHVS) global pitch
NEW: Clinical Trial using PuREC’s Rapid Expanding Cells for Hypophosphatase (HPP) Disease
Joint research collaboration with Hokkaido University and Mochida Pharmaceutical
PuREC wins JHVS2020 Venture Award !